La Flor de Oro de la Salud
FDA import alert and refusal historyBachiniva Chihuahua C, MexicoFEI 3012882478
Recorded by FDA as LA FLOR DE ORO DE LA SALUD
As of October 26, 2026, La Flor de Oro de la Salud is not on any FDA import alert in SupplierRadar's records; FDA refused 5 of its shipment lines between September 23, 2019 and July 1, 2024, most often for required label information not in english (NO ENGLISH).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · NO ENGLISH
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for La Flor de Oro de la Salud
5 records, newest first. Each line links to the FDA page it came from.
2024
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.NO ENGLISHUNAPPROVEDEntry AEK-5307307-6Source
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.NO ENGLISHUNAPPROVEDEntry AEK-5305242-7Source
- Import refusalRefused, Glucosamine sulfate (herbal and botanicals, not teas ii)NO ENGLISHUNAPPROVEDEntry AEK-5309649-9Source
2023
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.LIST INGRELACKS FIRMNO ENGLISHLABELINGEntry AEK-2454889-1Source
2019
- Import refusalRefused, Vitamin, n.e.c.NOT LISTEDUNAPPROVEDEntry 799-3075345-2Source
Refusal charges, in plain English
- NO ENGLISH4 refused lines
Required label information not in English
Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.
- UNAPPROVED4 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
- LABELING1 refused line
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- LACKS FIRM1 refused line
Manufacturer name and address missing
The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.
- LIST INGRE1 refused line
Ingredients not listed
The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).
- NOT LISTED1 refused line
Product not listed with FDA
The product appeared to be a drug or device that is not included in the listing FDA requires under section 510(j) of the FD&C Act.
Questions about La Flor de Oro de la Salud
- Is La Flor de Oro de la Salud on an FDA import alert?
- No listing for La Flor de Oro de la Salud appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Mexico page.
- Has FDA refused shipments from La Flor de Oro de la Salud?
- Yes. FDA refused 5 shipment lines from La Flor de Oro de la Salud between September 23, 2019 and July 1, 2024. The most recent, on July 1, 2024, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as NO ENGLISH (required label information not in english).
- Why did FDA refuse La Flor de Oro de la Salud's shipments?
- The most frequent charges are NO ENGLISH (required label information not in english, 4 lines) and UNAPPROVED (unapproved new drug, 4 lines).
- What is La Flor de Oro de la Salud's FEI number?
- La Flor de Oro de la Salud's FDA Establishment Identifier (FEI) is 3012882478.
Buying from La Flor de Oro de la Salud?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.